English
简体中文
Total: £ 56.28
2025-09-04 | Pages: 102 | Tables: 105
The global market for Probiotic-based Dietary Supplements was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.Probiotic-based dietary supplements...
2025-09-04 | Pages: 85 | Tables: 83
The global market for OTC Consumer Health Products (Powder Form) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.North American market for OT...
2025-09-04 | Pages: 69 | Tables: 70
The global market for Urokinase for Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.Urokinase, also known as urokinase-type plasmin...
2025-09-04 | Pages: 80 | Tables: 82
The global market for Xylitol in Pharmaceutical was valued at US$ 23.8 million in the year 2024 and is projected to reach a revised size of US$ 33.3 million by 2031, growing at a CAGR of 5.0% during the forecast period.Xylitol is a derivative of xylo...
2025-09-04 | Pages: 73 | Tables: 75
The global market for Haemorrhagic Stroke Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.For the appropriate management of hemorrhagic...
2025-09-04 | Pages: 90 | Tables: 90
The global market for Spirulina Tablet was valued at US$ 41.3 million in the year 2024 and is projected to reach a revised size of US$ 51.6 million by 2031, growing at a CAGR of 3.3% during the forecast period.North American market for Spirulina Tabl...
2025-09-04 | Pages: 87 | Tables: 79
The global market for Therapeutic BCG Vaccines was valued at US$ 362 million in the year 2024 and is projected to reach a revised size of US$ 441 million by 2031, growing at a CAGR of 2.9% during the forecast period.The global pharmaceutical market i...
2025-09-04 | Pages: 84 | Tables: 84
The global market for Hard HPMC Capsule was valued at US$ 266 million in the year 2024 and is projected to reach a revised size of US$ 494 million by 2031, growing at a CAGR of 9.4% during the forecast period.HPMC capsules incorporate a gelling agent...
2025-09-04 | Pages: 83 | Tables: 82
The global market for Fulvestrant was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.North American market for Fulvestrant is estimated to incre...
2025-09-04 | Pages: 71 | Tables: 68
The global market for Goserelin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.North American market for Goserelin is estimated to increase ...
2025-09-04 | Pages: 72 | Tables: 71
The global market for Daratumumab was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.North American market for Daratumumab is estimated to incre...
2025-09-04 | Pages: 68 | Tables: 75
The global market for Naldemedine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.North American market for Naldemedine is estimated to incre...
2025-09-04 | Pages: 68 | Tables: 71
The global market for Siltuximab was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.North American market for Siltuximab is estimated to increas...
2025-09-04 | Pages: 70 | Tables: 69
The global market for Indacaterol was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.North American market for Indacaterol is estimated to incre...
2025-09-04 | Pages: 67 | Tables: 62
The global market for Afatinib was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.North American market for Afatinib is estimated to increase fr...
